Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aspect Medical Systems
Aspect antidepressant response index accurately predicts patient response to SSRI's
June 23rd, 2006
Findings from two studies presented at the annual meeting of the American Psychiatric Association document the capability of Aspect Medical System's EEG-based research technology to predict an individual's likelihood of responding to treatment of depression with an SSRI at 1 week after initiating medication. Typically, it takes several weeks to determine if a patient has responded to a specific antidepressant regimen, causing some patients to stop taking medications early and delaying the identification of a more efficacious regimen. The studies, conducted at Massachusetts General Hospital (MGH; Boston, Massachusetts) and Cedars Sinai Medical Center...
Source: Biotech Law Weekly (2006-06-23)
|
